HackerTrans
热门最新趋势评论往期问答秀出招聘

deepzn

no profile record

评论

deepzn
·6个月前·讨论
Daft Punk is one of my favorite artists ever but I am not familiar with all their discography(my shame and I mean to remedy that). But this was such a cool read from an obvious bigger fan than me. Half way through was only when I realized the significance of a BPM of 123.45, I didn't read it out without the decimal until then lol. And so many more fans in the comments, wow.
deepzn
·4年前·讨论
Ohhh, snap, I wish I'd stopped at spoiler alert..... :(((( haha it's all good. I'd been meaning to read those for a while, but...alas never did.
deepzn
·4年前·讨论
He did it, but still would have a preferred a Dune TV show, especially after the success of GoT, and the streaming wars. The money was there. Characters played by Jason Momoa, Oscar Issac etc only got a little bit of screen time. And all those cool characters would have been amazing to watch over a few seasons.
deepzn
·4年前·讨论
not villages necessarily, families look out for each other, everyone's own kin.
deepzn
·4年前·讨论
real cool, thx for sharing!
deepzn
·4年前·讨论
If you do have enough financial means, or parents, etc that are understanding. Quit the job, and take a break. Sometimes you just need to cut the cord. Do some travel, exercise, yoga/meditation, meeting and hanging with people you love or doing hobbies you like or always wanted to explore. A lot of us get stuck into jobs we hate, even though we have the means and options to not keep doing it. Wishing you the best! You got this.
deepzn
·5年前·讨论
This company Compass Pathways is one that is doing clinical trials for psilocybin treatments, hopefully they can be purchased with a prescription sometime this decade or in a few years. More info from the company: "We received FDA Breakthrough Therapy designation for our programme of psilocybin therapy in treatment-resistant depression in 2018. We are conducting a randomised controlled phase IIb study of psilocybin therapy in 216 patients with treatment-resistant depression in 22 sites across Europe and North America"

"We are working as quickly as we can to develop psilocybin therapy for people suffering with treatment-resistant depression. We expect to report data from our phase IIb by the end of the year. If the results are positive, we then plan to begin a phase III study in 2022. Details of the sites that will be involved in this phase will be provided here as soon as they have been approved."

https://compasspathways.com/our-research/psilocybin-therapy/...